GMFG

Glia maturation factor gamma · O60234 · GMFG on Sugi Atlas →

0 patent compounds predicted against GMFG, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to GMFG by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Minocycline to Treat Childhood Regressive Autism PHASE4COMPLETED
Phase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell Lymphoma PHASE1/PHASE2RECRUITING
Phase 2A Study of GM 608 in Mild to Moderate Parkinson Disease PHASE2COMPLETED
GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS) PHASE2COMPLETED
A Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas PHASE2COMPLETED
Discovery and Validation of Genetic Variants Affecting Microglial Activation in Alzheimer's Disease PHASE2ACTIVE_NOT_RECRUITING
Intranasal Inhalations of Bioactive Factors Produced by M2 Macrophages in Patients With Organic Brain Syndrome PHASE1/PHASE2COMPLETED
Safety and Efficacy of Tag-7 Gene-modified Vaccine in Locally Advanced or Metastatic Malignant Melanoma or Kidney Cancer PHASE1/PHASE2COMPLETED
Mesenchymal Stem Cells Transplantation to Patients With Parkinson's Disease PHASE1/PHASE2UNKNOWN
Study of [11C]CPPC as a Clinical PET Radioligand Biomarker of Microglial Activation in ALS PHASE1/PHASE2NOT_YET_RECRUITING
A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients PHASE2COMPLETED
Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors PHASE2UNKNOWN
Intranasal Inhalations of M2 Macrophage Soluble Factors in Children With Developmental Speech Disorders PHASE1/PHASE2COMPLETED
Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma PHASE1/PHASE2COMPLETED
Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas PHASE1/PHASE2COMPLETED
Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 PHASE1ACTIVE_NOT_RECRUITING
Vaccine Therapy in Treating Patients With Recurrent Glioblastoma EARLY_PHASE1COMPLETED
Treatment of Spinal Cord Injury Using Autologous Concentrated Growth Factors EARLY_PHASE1NOT_YET_RECRUITING
Developing a Functional Cure for HIV Disease: Clinical Specimen Collection From HIV Positive Individuals nanUNKNOWN
Fatigue in Multiple Sclerosis and Its Relationship to Inflammatory and Neurodegenerative Markers of the Disease nanENROLLING_BY_INVITATION
Longitudinal Assessment of Iron Rims in MS Lesions nanRECRUITING
Patient-derived Glioma Stem Cell Organoids nanACTIVE_NOT_RECRUITING
The Role of Epigenetic Modifications in Autism Spectrum Disorder nanUNKNOWN
The Cognitive-Behavioral Dysfunctions and the Potential of Neuroplasticity in Brain Tumors Patients During Radiotherapy nanUNKNOWN
IDH1 and OCT4 in High Grade Astrocytoma nanRECRUITING
The Influence of Ventilation on Perioperative Neurocognitive Disorders nanWITHDRAWN
Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients nanCOMPLETED
Blood-Based Molecular Clock Biomarkers Predict Acute Ischemic Stroke Onset: A Prospective Observational Study nanACTIVE_NOT_RECRUITING
HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors) nanUNKNOWN
Utility of Primary Glioblastoma Cell Lines nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a GMFG binder may also engage these)

ProteinNameSimilarity
Q56JZ9 1.000 Q56JZ9 →
Q5R6P6 0.998 Q5R6P6 →
P60984 0.997 P60984 →
P60983 0.996 P60983 →
Q9ERL7 0.994 Q9ERL7 →
Q63228 0.993 Q63228 →
Q80T18 0.989 Q80T18 →
Q9CQI3 0.986 Q9CQI3 →
Q6B7M7 0.959 Q6B7M7 →
Q4R5C0 0.958 Q4R5C0 →
Q5E9F7 0.958 Q5E9F7 →
P10668 0.958 P10668 →
P45592 0.957 P45592 →
CFL1 Cofilin-1 0.957 landscape →
P18760 0.955 P18760 →
Q5XHH8 0.954 Q5XHH8 →
Q5U4Y2 0.953 Q5U4Y2 →
Q9D662 0.948 Q9D662 →
Q5R5G2 0.948 Q5R5G2 →
Q5ZK03 0.945 Q5ZK03 →
Q148F1 0.945 Q148F1 →
Q9Y281 0.944 Q9Y281 →
Q5G6V9 0.944 Q5G6V9 →
SEC23B Protein transport protein Sec23B 0.944 landscape →
Q96JJ3 0.943 Q96JJ3 →
Q3B8M3 0.943 Q3B8M3 →
B0BN93 0.943 B0BN93 →
Q5ZLA5 0.942 Q5ZLA5 →
P45591 0.942 P45591 →
Q28C65 0.942 Q28C65 →